Home » Clinical Trials » Search Clinical Trials
Parent Therapeutic Areas: Neurology

Alzheimer's Disease

Alabama

Birmingham : Univeristy of Alabama Alzheimer's Disease Research Center

Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease

Arizona

Phoenix : Xenoscience Inc.

Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease

Phoenix : Banner Alzheimer's Institute

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Sun City : Banner Sun Health Research Institute

ABT-089, an investigational drug for the treatment of mild to moderate Alzheimer's Disease

Sun City : Banner Sun Health Research Institute

Phase II - ACC-001 Vaccine treatment for mild to moderate Alzheimer's Disease, trial study

Sun City : Banner Sun Health Research Institute

Phase III - Avandia treatment for Alzheimer's disease as a means to reduce inflammation and increase sugar uptake in the brain.

Sun City : Banner Sun Health Research Institute

Phase IV - Alzheimer's Disease Once-a-day Patch Medication, Trial Study

Tucson : Northwest NeuroSpecialists, PLLC

Alzheimer's Disease Clinical Research Study

Tucson : Northwest NeuroSpecialists, PLLC

Alzheimer's Disease Clinical Research Study

Tucson : Northwest NeuroSpecialists, PLLC

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Various Cities : Research Center New!

Alzheimer?s Disease Study CENA713DUS44

Arkansas

Little Rock : Clinical Trials, Inc.

Mild to Moderate Alzheimer's disease

Little Rock : Clinical Trials, Inc.

Mild to Moderate Alzheimer's disease

Various Cities : Research Center New!

Alzheimer?s Disease Study CENA713DUS44

California

Encino : Pharmacology Research Institute, Encino

Study of an investigational medication for the treatment of Alzheimer's Disease

Fresno : The Margolin Brain Institute

ALZHEIMER’S DISEASE RESEARCH STUDY

Fresno : The Margolin Brain Institute

Alzheimer’s Disease Research Study Opportunity Currently Available

Fresno : The Margolin Brain Institute

Alzheimer’s Research Study

Fresno : The Margolin Brain Institute

For people with Alzheimer's there's no time to lose.

Fresno : The Margolin Brain Institute

Global early-stage research study to evaluate an investigational medication for early-stage Alzheimer’s disease

Fresno : The Margolin Brain Institute

Please take note of our Alzheimer's disease clinical research study.

Garden Grove : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Garden Grove : CNS Networks, Inc.

Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease

Glendale : California Clinical Trials Medical Group, Inc.

Alzheimer's Disease Study

Lafayette : Bay Area Research Institute

Bay Area Research Institute is conducting a clinical research trial of an investigational intravenous medication for mild to moderate Alzheimer’s disease in people between 50 and 88 years of age.

Lafayette : Bay Area Research Institute

Bay Area Research Institute is conducting a clinical research trial of an investigational study medication in improving learning and memory in people with Alzheimer’s Disease.

Los Alamitos : Pharmacology Research Institute, Los Alamitos

Study of an investigational medication for the treatment of Alzheimer's Disease

National City : Synergy Clinical Research Center

Alzheimer's Disease - Memory Loss

National City : Synergy Clinical Research Center

Alzheimer's Disease - Memory Loss

Newport Beach : Pharmacology Research Institute, Newport Beach

Study of an investigational medication for the treatment of Alzheimer's Disease

Oxnard : Pacific Neuroscience Medical Group, Inc. New!

Alzheimer's Research Study in Ventura County

Oxnard : Pacific Neuroscience Medical Group, Inc. New!

Alzheimer's Research using Anti-Amyloid Beta Antibody in Ventura County

Palo Alto : Stanford University School of Medicine

Cholesterol lowering agents to slow progression of Alzheimer's disease (CLASP study)

Rancho Mirage : Southwest Institute for Clinical Research

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Redlands : Anderson Clinical Research

Study of an investigational medication for the treatment of Alzheimer's Disease

Sacramento : Sutter Institute for Medical Research (SIMR)

Alzheimer’s Disease

San Diego : Pacific Research Network

Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease

San Diego : Pacific Research Network

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

San Francisco : San Francisco Clinical Research Center

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Santa Ana : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Santa Ana : Apex Research Institute

Alzheimers? Be a Part of Research.

Sherman Oaks : Schuster Medical Research Institute

JOIN THE FIGHT AGAINST ALZHEIMER’S DISEASE

Sherman Oaks : California Neuroscience Research Medical Group, Inc.

Research study of a currently marketed medication for Alzheimer’s Disease.

Sherman Oaks : California Neuroscience Research Medical Group, Inc.

Research study of an investigational medication for those who are at risk to develop Alzheimer’s Disease.

Various Cities : Research Center New!

Alzheimer?s Disease Study CENA713DUS44

Colorado

Boulder : Alpine Clinical Research Center

Evaluation of a investigational oral medication for patients with Alzheimer’s Disease.

Boulder : Alpine Clinical Research Center

New Investigational Medication for Alzheimer’s disease

Boulder : Alpine Clinical Research Center New!

New treatment aimed at slowing down the progression of Alzheimer’s disease

Denver : Radiant Research - Denver

Alzheimer’s Disease

Denver : Radiant Research - Denver

Alzheimer’s? Questions about treatment options?

Denver : Radiant Research - Denver

Alzheimer's Disease Research

Denver : Radiant Research - Denver

Do you know or care for someone currently taking Aricept® for alzheimer's?

Denver : Radiant Research

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Denver : Radiant Research - Denver

If you or someone you know is experiencing memory loss, they may qualify for a clinical research study currently being conducted by Radiant Research.

Denver : Radiant Research - Denver

Research for Alzheimer's Disease

Various Cities : Research Center New!

Alzheimer?s Disease Study CENA713DUS44

Connecticut

Hamden : Geriatric and Adult Psychiatry, LLC

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Norwalk : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Norwalk : Research Center for Clinical Studies

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Pawcatuck : CNS Research of CT, Inc.

The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility

Florida

Boynton Beach : NeuroPsychiatric Center of the Palm Beaches

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Bradenton : Bradenton Research

Alzheimer's Disease Clinical Study

Brooksaville : Meridien Research

Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease

Delray Beach : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Delray Beach : Brain Matters Research

Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease

Ft. Myers : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Gainesville : Center for Clinical Trials Research, University of Florida

Clinical trial to assess the safety and tolerability of multiple oral doses of an investigational drug in elderly subjects with mild or moderate Alzheimer's disease on a stable dose of 10mg of Aricept daily.

Hallandale Beach : MD Clinical

Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease

Maitland : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Maitland : Florida Clinical Research Center, LLC

Alzheimer's Disease

Miami Springs : Galiz Research

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Naples : Anchor Research Center

Alzheimer's study.

Naples : Anchor Research Center

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Ocala : Renstar Medical Research

Alzheimer's Disease

Ocala : Renstar Medical Research

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Ocala : Renstar Medical Research

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Orlando : Compass Research

Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease

Palm Beach Gardens : Palm Beach Neurological Center`

Alzheimer's Disease

Palm Beach Gardens : Palm Beach Neurological Center New!

Alzheimer's study

St. Petersburg : Comprehensive NeuroScience Inc. St. Petersburg New!

St. Petersburg, FL - Alzheimer''s Disease

Tampa : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Tampa : Axiom Clinical Research of Florida

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Tampa : University of South Florida

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Various Cities : Research Center New!

Alzheimer?s Disease Study CENA713DUS44

Venice : Center for Clinical Trials

Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease

West Palm Beach : Premiere Research Institute

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Georgia

Atlanta : CNS Clinical Trials, Atlanta

Do you have a loved one with Alzheimer's Disease?

Atlanta : Neurotrials Research, Inc.

Do you have mild to moderate Alzeimer's Disease?

Columbus : Columbus Research & Wellness Institute

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Idaho

Various Cities : Research Center New!

Alzheimer?s Disease Study CENA713DUS44

Illinois

Chicago : Radiant Research - Chicago

Alzheimer's Disease Research

Various Cities : Research Center New!

Alzheimer?s Disease Study CENA713DUS44

Indiana

Indianapolis : Indiana University

Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease

Indianapolis : Agewell

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Various Cities : Research Center New!

Alzheimer?s Disease Study CENA713DUS44

Kansas

Various Cities : Research Center New!

Alzheimer?s Disease Study CENA713DUS44

Kentucky

Lexington : Associates in Neurology, P.S.C.

Phase 3 trial evaluating Treatment with intravenous Bapineuzumab vs. Placebo for Alzheimer's disease

Paducah : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Paducah : Four Rivers Clinical Research

Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease

Louisiana

Lake Charles : Lake Charles Clinical Trials

Randomized, Double blind, placebo controlled, parallel group, efficacy and safety trial of bapineuzumab in patients with mild to moderate Alzheimer's disease

Shreveport : Psychopharmacology Research Clinic LSUHSC-Shreveport

Alzheimer's Fades Memories To explore new ways of slowing the disease progression, we need your help.

Various Cities : Research Center New!

Alzheimer?s Disease Study CENA713DUS44

Maryland

Various Cities : Research Center New!

Alzheimer?s Disease Study CENA713DUS44

Massachusetts

Bellingham : CNS Research of MA, Inc.

The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility

Boston : Brigham and Women's Hospital New!

A Multicenter, Randomized, Double-Blind, Placebo-Controlled
Study of the Safety, Tolerability, Pharmocodynamic and Pharmacokinetic
Effects of BMS-708163 in the Treatment of Patients With Prodromal
Alzheimer's Disease

Boston : Brigham and Women's Hospital New!

CONCERT: A Phase 3 Multicenter, Randomized, Placebo-Controlled, Double-Blind Twelve-Month Safety and Efficacy Study Evaluating Dimebon in Patients with Mild-to-Moderate Alzheimer’s Disease on Donepezil

Various Cities : Research Center New!

Alzheimer?s Disease Study CENA713DUS44

West Yarmouth : Clinical Research Center of Cape Cod, Inc

Are you facing Alzheimer’s?

Michigan

Kalamazoo : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Kalamazoo : Borgess Research Institute

A study to determine the effectiveness of an investigational medication in the treatment of Alzheimer's Disease.

Various Cities : Research Center New!

Alzheimer?s Disease Study CENA713DUS44

Mississippi

Hattiesburg : Hattiesburg Clinic Neurological Research Center New!

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Efficacy and Safety Trial of Bapineuzumab in Subjects With Mild to Moderate Alzheimer Disease Who Are Apolipoprotein E e4 Carriers

Hattiesburg : Hattiesburg Clinic Neurological Research Center New!

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Trial of Bapineuzumab (AAB-001, ELN115727) In Patients With Mild to Moderate Alzheimer's Disease Who Are Apolipoprotein E4 Non- Carriers

Hattiesburg : Hattiesburg Clinic Neurological Research Center New!

Effect of LY450139 a y-Secretase Inhibitor, on the Progression of Alzheimer's Disease as Compared With Placebo

Hattiesburg : Hattiesburg Clinic Neurological Research Center New!

Effect of Passive Immunization on the Progression of Alzheimer's Disease: LY2062430 Versus Placebo

Various Cities : Research Center New!

Alzheimer?s Disease Study CENA713DUS44

Missouri

St. Louis : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Various Cities : Research Center New!

Alzheimer?s Disease Study CENA713DUS44

Montana

Billings : Billings Clinic Research Center

Are you or someone you know between the ages of 50 and 89 years of age with a diagnosis of mild to moderate Alzheimer's Disease?

Various Cities : Research Center New!

Alzheimer?s Disease Study CENA713DUS44

Nebraska

Various Cities : Research Center New!

Alzheimer?s Disease Study CENA713DUS44

Nevada

Las Vegas : Cleveland Clinic-Lou Ruvo Center for Brain Health

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

New Jersey

Eatontown : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Eatontown : Memory Enhancement Centerof America, Inc.

Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease

Princeton : Princeton Medical Institute

Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease

Stratford : University of Medicine and Dentistry of New Jersey - School of Osteopathic Medicine

Alzheimer's disease study for mild to moderate AD.

Toms River : Memory Enhancement Center of America

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Various Cities : Research Center New!

Alzheimer?s Disease Study CENA713DUS44

New Mexico

Albuquerque : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Various Cities : Research Center New!

Alzheimer?s Disease Study CENA713DUS44

New York

Brooklyn : Brooklyn Medical Institute

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

New Hyde Park : Parker Jewish Institute

Parker Jewish Institute for Health Care & Rehabilitation Seeks Study Volunteers with Alzheimer's Disease

Rochester : University of Rochester Medical Center

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Staten Island : Richmond Behavioral Associates

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Various Cities : Research Center New!

Alzheimer?s Disease Study CENA713DUS44

White Plains : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

North Carolina

Charlotte : The Alzheimer's Memory Center

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Durham : Duke University Medical Center

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Morganton : MedARK Clinical Research

Do you or someone you care for have Alzheimer's Disease?

Raleigh : Raleigh Neurology Associates

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Raleigh : Wake Research Associates

Have you or someone you love been diagnosed with Alzheimer’s Disease?

Raleigh : Multi-Specialty Research Associates of NC

Is Alzheimer’s Disease affecting your loved one?

Various Cities : Research Center New!

Alzheimer?s Disease Study CENA713DUS44

Winston-Salem : Piedmont Medical Research

ALZHEIMER'S DISEASE: Don't let those memories fade…

Winston-Salem : Clinical Trials of America, Inc.

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Ohio

Toledo : Neurology & Neuroscience Center of Ohio

Alzheimer's Disease

Various Cities : Research Center New!

Alzheimer?s Disease Study CENA713DUS44

Oklahoma

Tulsa : Tulsa Clinical Research

Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease

Oregon

Portland : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Portland : Summit Research Network (Oregon), Inc.

Alzheimer's Research Study for People taking Aricept.

Portland : Summit Research Network (Oregon), Inc.

Memory Loss Research Study

Portland : Summit Research Network (Oregon), Inc.

Research Study for Agitation and Aggression Associated with Alzheimer’s Disease

Pennsylvania

Jenkintown : The Clinical Trial Center LLC

Clinical research study to evaluate an investigational medication for mild-to-moderate Alzheimer’s disease

Norristown : Keystone Clinical Studies, LLC

ALZHEIMER’S DISEASE

Norristown : Keystone Clinical Studies, LLC

BEHAVIOR & PERSONALITY CHANGES IN ALZHEIMER’S DISEASE

Norristown : Keystone Clinical Studies, LLC

SUFFERING FROM ALZHEIMER’S DISEASE?

Philadelphia : CRA Worldwide, LLD

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Various Cities : Research Center New!

Alzheimer?s Disease Study CENA713DUS44

Rhode Island

Providence : CNS Research of RI, Inc.

The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility

Various Cities : Research Center New!

Alzheimer?s Disease Study CENA713DUS44

Tennessee

Various Cities : Research Center New!

Alzheimer?s Disease Study CENA713DUS44

Texas

San Antonio : Radiant Research - San Antonio

Alzheimer’s Research Study

San Antonio : Radiant Research - San Antonio

Alzheimer's Disease Research

San Antonio : Innovative Clinical Trials

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

San Antonio : Clinical Trials of Texas, Inc.

Have you or someone you love been diagnosed with Alzheimer's Disease?

San Antonio : Radiant Research - San Antonio

Moderate to Severe Alzheimer’s

Various Cities : Research Center New!

Alzheimer?s Disease Study CENA713DUS44

Virginia

Richmond : Alliance Research Group

A clinical research trial evaluating an investigational drug for people with Alzheimer’s.

Various Cities : Research Center New!

Alzheimer?s Disease Study CENA713DUS44

Washington

Various Cities : Research Center New!

Alzheimer?s Disease Study CENA713DUS44

Wisconsin

Various Cities : Research Center New!

Alzheimer?s Disease Study CENA713DUS44

Waukesha : Independent Psychiatric Consultants

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Argentina

Buenos Aires : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Caba : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

La Plata : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Australia

Chermside : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Hornsby : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Woodville : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Canada

Kingston, ON : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

London, ON : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Medicine Hat, AB : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Montreal, QC : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Ottawa, ON : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Peterborough, ON : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Regina, SK : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

St. John, NB : St. Joseph's Hospital

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

Toronto, ON : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Tortonto, ON : Toronto Memory Program

Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease

France

Montpellier : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Nantes : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Nice : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Toulouse : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Germany

Günzburg : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Leipzig : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

München : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Nürnberg : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Israel

Ramat Gan : Research Site:

A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.

Italy

Castellanza : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Milano : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Napoli : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Mexico

Aguascalientes : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Guadalajara : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Monterrey : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Saltillo : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Netherlands

Amsterdam : Research Site:

A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.

Poland

Gdansk : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Leszno : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Torun : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Warszawa : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Romania

Bucharest : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Slovakia

Bratislava : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Michalovce : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Spain

Barakaldo : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Barcelona : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Madrid : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Malaga : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Salt : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Sweden

Huddinge : Research Site:

A Single Dose Study of R1450 in Patients With Alzheimer Disease.

Malmoe : Research Site:

A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.

Malmoe : Research Site:

A Single Dose Study of R1450 in Patients With Alzheimer Disease.

Stockholm : Research Site:

A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.

United Kingdom

Blackpool : Research Site:

A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.

Blackpool : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Bradford : Research Center

A Single Dose Study of R1450 in Patients With Alzheimer Disease.

Bradford : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Glasgow : Research Site:

A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.

Glasgow : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Southampton : Research Site:

A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.

Southampton : Research Site:

A Study of RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Swindon : Research Site:

A Multiple Ascending Dose Study of R1450 in Patients With Alzheimer Disease.